Pliant Therapeutics, Inc. (PLRX) Reports In-Line Q1 EPS

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q1 EPS of ($0.67), in-line with the analyst estimate of ($0.67). Revenue for the quarter came in at $1.33 million versus the consensus estimate of $1.4 million.

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• SWBI beats estimates by 71%, GEO nears 52-week high on policy tailwinds
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform